173 related articles for article (PubMed ID: 22179587)
1. The curcumin analogue hydrazinocurcumin exhibits potent suppressive activity on carcinogenicity of breast cancer cells via STAT3 inhibition.
Wang X; Zhang Y; Zhang X; Tian W; Feng W; Chen T
Int J Oncol; 2012 Apr; 40(4):1189-95. PubMed ID: 22179587
[TBL] [Abstract][Full Text] [Related]
2. New curcumin analogues exhibit enhanced growth-suppressive activity and inhibit AKT and signal transducer and activator of transcription 3 phosphorylation in breast and prostate cancer cells.
Lin L; Hutzen B; Ball S; Foust E; Sobo M; Deangelis S; Pandit B; Friedman L; Li C; Li PK; Fuchs J; Lin J
Cancer Sci; 2009 Sep; 100(9):1719-27. PubMed ID: 19558577
[TBL] [Abstract][Full Text] [Related]
3. Curcumin analogue GO-Y030 inhibits STAT3 activity and cell growth in breast and pancreatic carcinomas.
Hutzen B; Friedman L; Sobo M; Lin L; Cen L; De Angelis S; Yamakoshi H; Shibata H; Iwabuchi Y; Lin J
Int J Oncol; 2009 Oct; 35(4):867-72. PubMed ID: 19724924
[TBL] [Abstract][Full Text] [Related]
4. Curcumin blocks small cell lung cancer cells migration, invasion, angiogenesis, cell cycle and neoplasia through Janus kinase-STAT3 signalling pathway.
Yang CL; Liu YY; Ma YG; Xue YX; Liu DG; Ren Y; Liu XB; Li Y; Li Z
PLoS One; 2012; 7(5):e37960. PubMed ID: 22662257
[TBL] [Abstract][Full Text] [Related]
5. Novel STAT3 phosphorylation inhibitors exhibit potent growth-suppressive activity in pancreatic and breast cancer cells.
Lin L; Hutzen B; Zuo M; Ball S; Deangelis S; Foust E; Pandit B; Ihnat MA; Shenoy SS; Kulp S; Li PK; Li C; Fuchs J; Lin J
Cancer Res; 2010 Mar; 70(6):2445-54. PubMed ID: 20215512
[TBL] [Abstract][Full Text] [Related]
6. Hydrazinocurcumin Encapsuled nanoparticles "re-educate" tumor-associated macrophages and exhibit anti-tumor effects on breast cancer following STAT3 suppression.
Zhang X; Tian W; Cai X; Wang X; Dang W; Tang H; Cao H; Wang L; Chen T
PLoS One; 2013; 8(6):e65896. PubMed ID: 23825527
[TBL] [Abstract][Full Text] [Related]
7. Discovery of monocarbonyl curcumin-BTP hybrids as STAT3 inhibitors for drug-sensitive and drug-resistant breast cancer therapy.
Zhang W; Guo J; Li S; Ma T; Xu D; Han C; Liu F; Yu W; Kong L
Sci Rep; 2017 Apr; 7():46352. PubMed ID: 28397855
[TBL] [Abstract][Full Text] [Related]
8. Curcumin-Mediated Apoptotic Cell Death in Papillary Thyroid Cancer and Cancer Stem-Like Cells through Targeting of the JAK/STAT3 Signaling Pathway.
Khan AQ; Ahmed EI; Elareer N; Fathima H; Prabhu KS; Siveen KS; Kulinski M; Azizi F; Dermime S; Ahmad A; Steinhoff M; Uddin S
Int J Mol Sci; 2020 Jan; 21(2):. PubMed ID: 31936675
[TBL] [Abstract][Full Text] [Related]
9. Small molecules, LLL12 and FLLL32, inhibit STAT3 and exhibit potent growth suppressive activity in osteosarcoma cells and tumor growth in mice.
Onimoe GI; Liu A; Lin L; Wei CC; Schwartz EB; Bhasin D; Li C; Fuchs JR; Li PK; Houghton P; Termuhlen A; Gross T; Lin J
Invest New Drugs; 2012 Jun; 30(3):916-26. PubMed ID: 21340507
[TBL] [Abstract][Full Text] [Related]
10. Curcumin analogues exhibit enhanced growth suppressive activity in human pancreatic cancer cells.
Friedman L; Lin L; Ball S; Bekaii-Saab T; Fuchs J; Li PK; Li C; Lin J
Anticancer Drugs; 2009 Jul; 20(6):444-9. PubMed ID: 19384191
[TBL] [Abstract][Full Text] [Related]
11. Two small molecule compounds, LLL12 and FLLL32, exhibit potent inhibitory activity on STAT3 in human rhabdomyosarcoma cells.
Wei CC; Ball S; Lin L; Liu A; Fuchs JR; Li PK; Li C; Lin J
Int J Oncol; 2011 Jan; 38(1):279-85. PubMed ID: 21109950
[TBL] [Abstract][Full Text] [Related]
12. A novel small molecule inhibits STAT3 phosphorylation and DNA binding activity and exhibits potent growth suppressive activity in human cancer cells.
Lin L; Deangelis S; Foust E; Fuchs J; Li C; Li PK; Schwartz EB; Lesinski GB; Benson D; Lü J; Hoyt D; Lin J
Mol Cancer; 2010 Aug; 9():217. PubMed ID: 20712901
[TBL] [Abstract][Full Text] [Related]
13. Withaferin A inhibits activation of signal transducer and activator of transcription 3 in human breast cancer cells.
Lee J; Hahm ER; Singh SV
Carcinogenesis; 2010 Nov; 31(11):1991-8. PubMed ID: 20724373
[TBL] [Abstract][Full Text] [Related]
14. The Antitumoral Effect In Ovo of a New Inclusion Complex from Dimethoxycurcumin with Magnesium and Beta-Cyclodextrin.
Obregón-Mendoza MA; Meza-Morales W; Rodríguez-Hernández KD; Estévez-Carmona MM; Pérez-González LL; Tavera-Hernández R; Ramírez-Apan MT; Barrera-Hernández D; García-Olivares M; Monroy-Torres B; Nieto-Camacho A; Chávez MI; Sánchez-Obregón R; Enríquez RG
Int J Mol Sci; 2024 Apr; 25(8):. PubMed ID: 38673967
[TBL] [Abstract][Full Text] [Related]
15. Lysophosphatidic acid induces STAT3 phosphorylation and ovarian cancer cell motility: their inhibition by curcumin.
Seo JH; Jeong KJ; Oh WJ; Sul HJ; Sohn JS; Kim YK; Cho DY; Kang JK; Park CG; Lee HY
Cancer Lett; 2010 Feb; 288(1):50-6. PubMed ID: 19647363
[TBL] [Abstract][Full Text] [Related]
16. Curcumin inhibits oral squamous cell carcinoma proliferation and invasion via EGFR signaling pathways.
Zhen L; Fan D; Yi X; Cao X; Chen D; Wang L
Int J Clin Exp Pathol; 2014; 7(10):6438-46. PubMed ID: 25400722
[TBL] [Abstract][Full Text] [Related]
17. Curcumin suppresses vasculogenic mimicry capacity of hepatocellular carcinoma cells through STAT3 and PI3K/AKT inhibition.
Chiablaem K; Lirdprapamongkol K; Keeratichamroen S; Surarit R; Svasti J
Anticancer Res; 2014 Apr; 34(4):1857-64. PubMed ID: 24692720
[TBL] [Abstract][Full Text] [Related]
18. Curcumin inhibition of integrin (alpha6beta4)-dependent breast cancer cell motility and invasion.
Kim HI; Huang H; Cheepala S; Huang S; Chung J
Cancer Prev Res (Phila); 2008 Oct; 1(5):385-91. PubMed ID: 19138983
[TBL] [Abstract][Full Text] [Related]
19. I157172, a novel inhibitor of cystathionine γ-lyase, inhibits growth and migration of breast cancer cells via SIRT1-mediated deacetylation of STAT3.
Wang L; Shi H; Zhang X; Zhang X; Liu Y; Kang W; Shi X; Wang T
Oncol Rep; 2019 Jan; 41(1):427-436. PubMed ID: 30365149
[TBL] [Abstract][Full Text] [Related]
20. The antitumor activities of curcumin and of its isoxazole analogue are not affected by multiple gene expression changes in an MDR model of the MCF-7 breast cancer cell line: analysis of the possible molecular basis.
Poma P; Notarbartolo M; Labbozzetta M; Maurici A; Carina V; Alaimo A; Rizzi M; Simoni D; D'Alessandro N
Int J Mol Med; 2007 Sep; 20(3):329-35. PubMed ID: 17671737
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
